[Retracted] Clinical Efficacy and Safety of Tumor Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer

Table 3

VEGF levels (, µg/L).

Timepoint	Indices	Observation (n = 33)	Experimental (n = 33)	t-value	value
Before treatment	VEGFA	291.34 ± 40.11	289.68 ± 39.73	0.169	0.866
	VEGFB	365.87 ± 44.18	367.11 ± 40.68	−0.119	0.906
	VEGFC	232.42 ± 38.92	229.78 ± 41.74	0.266	0.791
After treatment	VEGFA	186.71 ± 21.39	102.37 ± 16.88	17.781	<0.001
	VEGFB	291.28 ± 23.14	143.84 ± 20.73	27.262	<0.001
	VEGFC	189.94 ± 25.21	92.46 ± 20.69	17.17	<0.001

Note. indicates when compared with pretreatment.